Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer

Annals of Thoracic Surgery

Volumn 73, Issue 3, 2002, Pages 905-910

  Kurdow, Roland ^a   Boehle, Arnd S ^a   Haye, Sieglinde ^a   Boenicke, Lars ^a   Schniewind, Bodo ^a   Dohrmann, Peter ^a   Kalthoff, Holger ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; GANCICLOVIR; PRODRUG; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GAP JUNCTION; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LUNG CANCER; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TUMOR GROWTH; VIRUS GENE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTIVIRAL AGENTS; CARCINOMA, SQUAMOUS CELL; CONNEXIN 43; DISEASE MODELS, ANIMAL; FEMALE; GANCICLOVIR; GENETIC VECTORS; HERPES SIMPLEX; HUMANS; LUNG NEOPLASMS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PRODRUGS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036186162     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03413-0     Document Type: Article

References (20)

1. Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene
2. Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model
3. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene
4. Herpes simplex virus thymidine kinase/ganciclovir-mediated apocptotic death of bystander cells
5. A. "distant" bystander effect of suicide gene therapy: Regression of non-transduced tumors together with a distant transduced tumor
6. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
7. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
8. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
9. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene
10. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo
11. Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase
12. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir
13. An improved orthotopic xenotransplant procedure for human lung cancer in SCID by mice
14. Kat: A high-efficiency retroviral transduction system for primary human T lymphocytes
15. Production of high-titer helper-free retroviruses by transient transfection
16. Transfection of DNA into eucaryotic cells
17. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer
18. Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines
19. Methylation of single sites within the herpes simplex virus tk coding region and the simian virus 40 T-antigen intron causes gene inactivation
20. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene